Phenprocoumon-induced hepatitis as an immunologically mediated drug allergic complication of antithrombotic therapy.
Dorn-Beineke
Alexandra
A
Institute of Clinical Chemistry, Laboratory for Haematology and Immunology, Faculty of Clinical Medicine Mannheim, University Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68135 Mannheim, Germany. alexandra.dorn-beineke@ikc.ma.uni-heidelberg.de
Hassan
Abdul-Wahab
AW
Bräutigam
Joachim
J
Hildenbrand
Ralf
R
Dempfle
Carl-Erik
CE
Schwab
Matthias
M
D000074:Acenocoumarol / Q000276:immunology; D000368:Aged; D003429:Cross Reactions / Q000276:immunology; D004342:Drug Hypersensitivity; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000276:immunology; D006505:Hepatitis / Q000209:etiology* / Q000276:immunology; D006801:Humans; D010644:Phenprocoumon / Q000009:adverse effects* / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D014859:Warfarin / Q000276:immunology
D005343:Fibrinolytic Agents; D014859:Warfarin; D000074:Acenocoumarol; D010644:Phenprocoumon